US Stock MarketDetailed Quotes
CRBP Corbus Pharmaceuticals
- 17.8500
- -0.1300-0.72%
Trading Nov 27 10:22 ET
217.40MMarket Cap-3789P/E (TTM)
18.1500High17.8500Low18.60KVolume17.9300Open17.9800Pre Close333.92KTurnover0.24%Turnover RatioLossP/E (Static)12.18MShares61.900052wk High1.44P/B138.48MFloat Cap4.937252wk Low--Dividend TTM7.76MShs Float323.4000Historical High--Div YieldTTM1.67%Amplitude2.1100Historical Low17.9530Avg Price1Lot Size
Corbus Pharmaceuticals Stock Forum
Sign in to post a comment
$Corbus Pharmaceuticals (CRBP.US)$
wow drop 62%. 😲
wow drop 62%. 😲
1
1
Got in at $16, this is gonna be a pretty long hold for me, wanna see how it plays out
5
3
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Hello Mooers! ![]()
A quick recap for the month ending April 30, 2024.
![]()
Ten stocks with >300% YTD
![]()
$Swvl Holdings (SWVL.US)$718.40%
![]()
$Root Inc (ROOT.US)$564.60%
![]()
$Elevation Oncology (ELEV.US)$561.08%
![]()
$JanOne (JAN.US)$554.05%
![]()
$GeneDx Holdings (WGS.US)$520.71%
![]()
$Corbus Pharmaceuticals (CRBP.US)$513.25%
![]()
$AGBA Group (AGBA.US)$482.90%
![]()
$Janux Therapeutics (JANX.US)$431.22%
![]()
$Dave Inc (DAVE.US)$4...
A quick recap for the month ending April 30, 2024.
4
1
$Corbus Pharmaceuticals (CRBP.US)$ Very strong uptrend, let's go high!
Dr. Smethurst's appointment, with his vast experience in oncology therapeutics, is viewed positively for Corbus. His leadership is anticipated to be key in the upcoming US dose escalation study for CRB-701 and the progression of other Corbus assets.
$Corbus Pharmaceuticals (CRBP.US)$ 50$/19$=2.63:1 ?
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
71013325 : because they shaking out all those that fold easily because it was an easy profit to predict